~~<i id='66FCD94956'><strike id='66FCD94956'><tt id='66FCD94956'><pre id='66FCD94956'></pre></tt></strike></i>~~

Home» explore» fashion

fashion

author：focus 2025-10-02 06:39:04 Page View：16956

Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry has argued the move will end badly for patients.

Beyond complaining about price controls and unconstitutional mandates, the key message aimed at the American public has been that innovation will suffer.

This is a familiar but tiring refrain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare explains how it will choose drugs for negotiation
Next article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

comprehensive

Continuity nursing helped my family in our darkest PICU moments

EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

Humans aren't the only ones with an imagination. Rats have it too

RYANM.KELLY/AFPviaGettyImagesOurmindshaveaweirdandwondrouswayoftransportingustootherplacesandtimes.Y

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

AstraZeneca bets AAV gene therapy will still deliver the goods

AlastairGrant/APSengChenghasbeenworkingingenetherapyfornearlyaslongasgenetherapyhasbeenafield.Asayou